Appraising the Current Role of Chemotherapy for the Treatment of Sarcoma

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Enzinger and Weiss's Soft Tissue Tumors

2001 • 2,340 citations

Cancer: Principles and Practice of Oncology.

1988 • 1,907 citations

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

1998 • 1,465 citations

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

2002 • 1,445 citations

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

2003 • 1,271 citations

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data

1997 • 1,013 citations

A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma

2008 • 895 citations

Soft-Tissue Sarcomas in Adults

2005 • 859 citations

Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

2003 • 845 citations

Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial

2001 • 688 citations

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

2005 • 685 citations

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

2007 • 682 citations

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

1992 • 674 citations

Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial

2002 • 670 citations

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data

1997 • 664 citations

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

1999 • 550 citations

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.

1987 • 528 citations

Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography

1979 • 525 citations

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

2009 • 522 citations

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

1995 • 519 citations

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

1993 • 504 citations

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

1993 • 473 citations

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

1988 • 461 citations

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

2007 • 453 citations

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

2005 • 422 citations

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

2005 • 418 citations

Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report

2000 • 418 citations

Secondary leukemias induced by topoisomerase-targeted drugs

1998 • 414 citations

A 14-Year Retrospective Review of Angiosarcoma

2005 • 385 citations

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

1997 • 378 citations

Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma

1996 • 370 citations

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study

2008 • 359 citations

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

2001 • 357 citations

Cancer Management: A Multidisciplinary Approach

2007 • 342 citations

Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup

2007 • 333 citations

Differential sensitivity of liposarcoma subtypes to chemotherapy

2005 • 329 citations

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.

1992 • 315 citations

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial

2008 • 293 citations

Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

1989 • 273 citations

Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.

1991 • 257 citations

Paclitaxel-induced neuropathy

1995 • 253 citations

Sarcoma

2007 • 252 citations

Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients

2008 • 249 citations

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

2007 • 244 citations

Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma

2004 • 229 citations

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

2009 • 227 citations

Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group

2008 • 221 citations

Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European group

2007 • 217 citations

Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group Study

2004 • 202 citations

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide

2003 • 187 citations

Dedifferentiated Chondrosarcoma: The Role of Chemotherapy with Updated Outcomes

2004 • 187 citations

Osteosarcoma over the age of forty

2002 • 185 citations

Ifosfamide in the Adjuvant Therapy of Soft Tissue Sarcomas

2003 • 178 citations

Dedifferentiated central chondrosarcoma

2006 • 176 citations

Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group Study

1991 • 167 citations

Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma

2003 • 164 citations

Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults

2008 • 141 citations

Adjuvant Chemotherapy of High-Grade Osteosarcoma of the Extremity

1991 • 137 citations

Experience in the treatment of dedifferentiated chondrosarcoma

2000 • 135 citations

Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series

2009 • 127 citations

Mesenchymal Chondrosarcoma. An Analysis of Patients Treated at a Single Institution

2007 • 125 citations

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

2002 • 120 citations

Adjuvant Epirubicin With or Without Ifosfamide for Adult Soft-Tissue Sarcoma

2002 • 112 citations

Myxoid liposarcoma. Experience with chemotherapy

1994 • 107 citations

Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): Interim analysis of a randomised phase III trial

2007 • 102 citations

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.

2000 • 97 citations

Neoadjuvant Chemotherapy With Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup Study

1999 • 86 citations

Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the french society of paediatric oncology

1997 • 85 citations

Phase II trial of gemcitabine in patients with advanced sarcomas (E1797)

2003 • 75 citations

Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma

2004 • 73 citations

Experience in the treatment of dedifferentiated chondrosarcoma

2000 • 64 citations

Treating soft tissue sarcomas with adjuvant chemotherapy

2011 • 59 citations

Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high‐risk osteosarcoma patients

2009 • 57 citations

Dose‐finding study of ¹⁵³Sm‐EDTMP in patients with poor‐prognosis osteosarcoma

2009 • 50 citations

Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).

2000 • 48 citations

Unique Features of the Mode of Action of ET-743

2002 • 47 citations

Hematologic Abnormalities and Acute Myeloid Leukemia in Children and Adolescents Administered Intensified Chemotherapy for the Ewing Sarcoma Family of Tumors

2000 • 46 citations

Histology-Driven Chemotherapy in Soft Tissue Sarcomas

2011 • 45 citations

Trabectedin therapy for sarcomas

2010 • 41 citations

Dosing and side-effects of ifosfamide plus mesna

1991 • 37 citations

Use of chemotherapy for patients with bone and soft-tissue sarcomas

2010 • 37 citations

Adjuvant chemotherapy in soft tissue sarcoma (STS): A meta-analysis of published data

2008 • 35 citations

Cellular transport and accumulation of thiotepa.

1990 • 33 citations

Adjuvant therapy for adult patients with soft tissue sarcomas.

1991 • 32 citations

Adjuvant therapy in the treatment of osteosarcoma.

1986 • 31 citations

Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma

2011 • 14 citations

Molecular Classification of Osteosarcoma

2009 • 13 citations

Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients (Cancer (2009) 115, (2980-2987))

2009 • 8 citations

Palifosfamide, a bifunctional alkylator for the treatment of sarcomas.

2010 • 3 citations

Phase II study of 153-samarium-EDTMP followed by haematopoietic stem cell for patients with osteosarcoma with bone metastasis.

2011 • 1 citations